Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
| Revenue (TTM) | $282.38B |
| Gross Profit (TTM) | $25.80B |
| EBITDA | $12.76B |
| Operating Margin | 3.99% |
| Return on Equity | 16.80% |
| Return on Assets | 4.46% |
| Revenue/Share (TTM) | $1069.94 |
| Book Value | $161.62 |
| Price-to-Book | 1.71 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 0.347 |
| EV/EBITDA | 7.64 |
| Quarterly Earnings Growth (YoY) | 10.20% |
| Quarterly Revenue Growth (YoY) | 6.70% |
| Shares Outstanding | $264.24M |
| Float | $262.92M |
| % Insiders | 1.44% |
| % Institutions | 92.24% |
Volatility is currently contracting
Jobs Growth: Slower but Steady Over time, growth in real GDP roughly equals the combination of productivity growth and labor force growth, and employment growth tracks the labor force (exhibit 1). When the business cycle rolls over, recessions push unemployment higher, and then recoveries bring it back down.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
BLOOMFIELD, Conn., Oct. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2026 financial results on Thursday, November 5, 2026, and will host a conference call the same day.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers and customers alike. Watch a demonstration of the new Health Sense customer experience.
Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. CI posted strong Q2 2026 results, raised full-year EPS guidance, and targets 10–14% annual EPS growth through 2030, driven by AI and specialty pharmacy. CI's asset-light model, expanding specialty pharma presence, and aggressive share buybacks support high-teens total return potential annually.
The Cigna Group (CI) Analyst/Investor Day Transcript
Cigna Group NYSE: CI reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day.
Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CI and any ticker you trade — then tracks every position and per-strategy win rate.
